Kore Private Wealth LLC Global Blood Therapeutics, Inc. Transaction History

Kore Private Wealth LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$52.76 - $74.49 $52,760 - $74,490	-1,000 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$45.7 - $81.86 $45,700 - $81,860	1,000 New	1,000 $79,000
Q2 2019 Aug 14, 2019	SELL	$52.6 - $63.29 $52,600 - $63,290	-1,000 Closed	0 $0
Q4 2018 May 23, 2019	BUY	$31.54 - $46.67 $31,540 - $46,670	1,000 New	1,000 $41,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Kore Private Wealth LLC, based on Form 13F filings with the SEC.

Stay updated on Kore Private Wealth LLC with notifications on news.